bioAffinity Technologies Inc
NASDAQ:BIAF

Watchlist Manager
bioAffinity Technologies Inc Logo
bioAffinity Technologies Inc
NASDAQ:BIAF
Watchlist
Price: 1.31 USD -4.38% Market Closed
Market Cap: 5.9m USD

Profitability Summary

bioAffinity Technologies Inc's profitability score is 21/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

21/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

21/100
Profitability
Score
21/100
Profitability
Score

Margins

Earnings Waterfall
bioAffinity Technologies Inc

Margins Comparison
bioAffinity Technologies Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
bioAffinity Technologies Inc
NASDAQ:BIAF
5.9m USD
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
378.3B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
178.1B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
154.2B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.3B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
85.3B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
41.9B EUR
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
46.9B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
bioAffinity Technologies Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
bioAffinity Technologies Inc
NASDAQ:BIAF
5.9m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
378.3B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
178.1B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
154.2B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.3B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
85.3B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
41.9B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
46.9B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
bioAffinity Technologies Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate